Month: January 2020
-
China launches new Alzheimer’s drug
What is Alzheimer’s disease? Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks. There are at least 50 million Alzheimer’s patients worldwide. Every year, there are nearly 10 million new cases. The thing about diseases like Alzheimer’s or dementia…
-
SAFETY ALERT – Drug labelling error – Mirtazapine Tablets (Aurobindo Pharma – USA)
Aurobindo Pharma, is voluntarily recalling lot number 03119002A3 of Mirtazapine Tablets. The product is being recalled due to a label error on declared strength; bottles labeled as Mirtazapine 7.5 mg may contain 15 mg tablets. Mirtazapine tablets are indicated for the treatment of major depressive disorder. Taking a higher dose than expected, may increase risk…
-
37. Introduction to Benefit-risk assessment
All medicines carry a certain level of risk. A totally safe and still fully effective medicine does not exist. Even penicillin, which has saved millions of lives can cause severe allergies, which can be deadly. Medicines provide therapeutic benefits (curing a disease, slowing its evolution, or alleviating its symptoms) but unfortunately, medicines also carrying risks…
-
GILENYA (fingolimod) – Safety update
GILENYA is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and children 10 years of age and older. This is the only FDA approved treatment for people with relapsing multiple sclerosis as young as 10. The most…